Joanna Ward
banner
jo-ward08.bsky.social
Joanna Ward
@jo-ward08.bsky.social
PhD student working with University of Lincoln Cardiorenal Group 👩🏼‍🔬 interested in #cardiovasculardisease #inflammation #diabetes #CKD
Views my own 💖
#cardiosky #nephrosky
Reposted by Joanna Ward
Delighted to see our protocol paper published today in @DiabeticMed led by PhD student @jo_ward08 @dmi_lincoln🧪👩‍🔬

We will explore how icosapent ethyl modulates macrophage-driven inflammation in patients with ASCVD ± T2D 🧬🧪
Results coming soon!

onlinelibrary.wiley.com/doi/10.1111/...
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library
Aims Despite intensive lipid-lowering therapy, individuals with atherosclerotic cardiovascular disease (ASCVD) exhibit residual inflammatory risk, which drives recurrent cardiovascular events. This ...
onlinelibrary.wiley.com
February 10, 2026 at 7:33 PM
Reposted by Joanna Ward
After the disappointment comes the reward 👩‍🔬👩‍🔬. What a month you've been November . Going out with a bang and celebrating these past 72hrs with two paper acceptances and one grant award 🥂🥳🎊 . #WomeninSTEM. #DiabetesResearch #CardioRenal #cardiovascular #inflammation #WomeninScience
November 20, 2025 at 6:29 PM
Reposted by Joanna Ward
The final piece of good news for 2025 came through 🥳🥳 and it was the perfect excuse to open this beauty 🥂🍾🎄🌲. Toasting my wonderful dream team and colleagues 👩‍🔬👨‍🔬🧪🥼 #type2diabetes #diabetes #cardiovascular #cardiovasculardisease #inflammation #papersuccess #grantsuccess
December 13, 2025 at 7:02 PM
Reposted by Joanna Ward
Fantastic end to a few days away at European Society of Cardiology , in sunny Madrid #ESCcongress with an amazing team & opportunity to hear about all the latest developments.👩‍🔬🥼🧪 #cardiovascular #cardiovasculardisease #WomenInSTEM #inflammation #cardioSky #NephroSky
September 1, 2025 at 7:20 PM
Reposted by Joanna Ward
📣 Contributions of Noncardiac Organ–Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives 👇👇👇👇 #cardiovascular #cardiosky #nephsky #WomenInSTEM #cardiorenal #inflammation #immune

www.ahajournals.org/doi/10.1161/...
Contributions of Noncardiac Organ–Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives | Circulation Research
Heart failure is the final outcome of most cardiovascular diseases and shares risk factors with other cardiovascular pathologies. Among these, inflammation plays a central role in disease progression ...
www.ahajournals.org
May 23, 2025 at 8:58 PM
Another fabulous output from team Cardiorenal 👏🏻👏🏻 that fizz is so well deserved @chillslincoln79.bsky.social 🥳🥳🥳🥰 #womeinstem #womeninscience #cardioresearch #diabetesresearch #SGLT2i
Paper published today 🥳🥳🥳 no better excuse to celebrate. Enjoy all the wins, no matter how small. 👩‍🔬🥼🧪 #Saturdaynight #WomenInSTEM #academiclife #Cardiovascularresearch #diabetes #type2diabetes #NephSky #Lincolnshire #healthcareinequalities #sglt2i #cardiometabolic #cardiorenal #cardiosky
April 28, 2025 at 8:43 PM
Reposted by Joanna Ward
📣Team output led by Dr Usman Shah from the University of Lincoln. 'Optimisation of care among patients with diabetes mellitus & acute coronary syndrome through a specialised cardiodiabetes service—A registry study'. 👇 👇 #Diabetes #Cardiovascular
onlinelibrary.wiley.com/doi/full/10....
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library
Aims Diabetes mellitus remains a prevalent condition worldwide and a significant risk factor for atherosclerotic cardiovascular disease. Recent evidence suggests the use of glucose-lowering therapie.....
onlinelibrary.wiley.com
April 3, 2025 at 5:25 PM
Reposted by Joanna Ward
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review 👩‍🔬🥼🧪👨‍🔬 #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease 👇👇👇

www.ahajournals.org/doi/epub/10....
www.ahajournals.org
March 12, 2025 at 8:26 AM
Wonderful to see the work of the brilliant @chillslincoln79.bsky.social highlighted for this #worldkidneyday 👩🏼‍🔬👏🏻 so so deserving of this recognition- you are incredible 👏🏻🥰 #womeninstem #womeninscience #nephsky #cardiosky #phdchat #phdlife
March 13, 2025 at 10:33 PM
Reposted by Joanna Ward
Dapagliflozin improves estimated CVD and ESKD risk in T1D participants, emphasizing the need for cardiorenal outcome trials in people living with T1D. bit.ly/CJASN0641
#ASNCJASN
March 5, 2025 at 6:15 PM
Beautiful sunsets and wine for a Saturday night 🥰🥰 #womeninstem #academicchatter #nephsky #cardiosky #cardioresearch #phdchat #phdlife #happysaturday
March 1, 2025 at 6:32 PM
Reposted by Joanna Ward
Two years of empagliflozin slowed kidney disease progression and reduced cardiovascular risk. In the follow-up study to the EMPA-KIDNEY trial, empagliflozin had additional cardiorenal benefits after discontinuation. Full study results: nej.md/3NE3W7K

#MedSky #Nephrology #CardioSky
February 25, 2025 at 8:16 PM
Reposted by Joanna Ward
Congratulations to my PhD student Joanna Ward for
winning 'Best presentation' at yesterdays PGR Showcase on her talk 'Investigating a role for #Vazkepa in mitigating chronic inflammation as observed in atherosclerosis' so proud of you 👏 🥳 #Diabetes #CardiovascularDisease #WomeninSTEM #cardiosky
February 27, 2025 at 6:27 PM
February 23, 2025 at 9:32 PM
Reposted by Joanna Ward
Effect of #sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial 👩‍🔬🥼🧪👨‍🔬 #cardiosky #SGLT2i #SGLT1/2 #cardiovascular #womeninstem #NephSky 👇👇👇

www.thelancet.com/journals/lan...
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Sotagliflozin reduced MACE, with independent reductions in myocardial infarction and stroke, among patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk. The ischae...
www.thelancet.com
February 16, 2025 at 10:45 PM
Reposted by Joanna Ward
Today is #InternationalDayofWomenandGirlsinScience 👩‍🔬🥼🧪 & what better way to acknowledge this than to celebrate my fabulous female team at @unilincoln 🥳🥳 . Thank-you for everything you do in the name of research 👏👏👏 #Diabetes #nephsky #cardiosky #kidneydisease #cardiorenal #WomenInSTEM
February 11, 2025 at 4:34 PM
Celebrating #InternationalDayofWomenInScience with a shoutout to the FABULOUS @chillslincoln79.bsky.social 🥰 a constant source of positivity, kindness and wisdom 👩🏼‍🔬 you are a truly inspiring #womaninstem and team @UoLCardioRenal are incredibly lucky to have you 🥳❤️ 👏🏻#phdlife #nephsky #cardiosky
February 11, 2025 at 9:07 AM
Last PBMC isolation of the week!! Happy Friday 🥳🥳 #womeninstem #womeninscience #phdsky #nephsky #cardiosky #happyfriday #cardioresearch #phdchat #phdlife
February 7, 2025 at 11:03 AM
February 2, 2025 at 3:19 PM
Reposted by Joanna Ward
📣 Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-clinical trial @naturemedicine.bsky.social 👩‍🔬🥼🧪👨‍🔬 #Semaglutide #KidneyDisease #Obesity #kidney #NephroSky #CardioSky #NephSky 👇👇👇
pubmed.ncbi.nlm.nih.gov/39455729/
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial - PubMed
Semaglutide reduces albuminuria and the risk of kidney disease progression in patients with type 2 diabetes and chronic kidney disease (CKD). We conducted a randomized placebo-controlled double-blind ...
pubmed.ncbi.nlm.nih.gov
January 29, 2025 at 6:16 PM
Reposted by Joanna Ward
📣 Novo Nordisk announces that the FDA has granted approval to its blockbuster drug Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes. 👩‍🔬🥼🧪👨‍🔬

#Semaglutide #diabetes #type2diabetes #nephropathy #GLP-1 👇👇

docwirenews.com/post/fda-app...
FDA Approves Ozempic for Kidney Disease | Docwire News
Based on FLOW trial results, the FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.
docwirenews.com
January 28, 2025 at 9:46 PM
Reposted by Joanna Ward
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors 👩‍🔬🥼👨‍🔬🧪 #CardioSky #SGLT2i #cardiovascular #cardiorenal #womeninSTEM #NephSky 👇👇
buff.ly/4ax2xdZ
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors - PubMed
This study found that individual SGLT-2 inhibitors demonstrated comparable cardiovascular effectiveness at clinically effective doses, though low-dose dapagliflozin showed a reduced benefit for heart ...
buff.ly
January 25, 2025 at 8:12 PM
Reposted by Joanna Ward
Congratulations @cardiacshah.bsky.social & co-author @jo-ward08.bsky.social from team #CardioRenal on publication of this all important review - incorporating clinical guidelines with latest evidence & experience in the management of T2DM in patients with ASCVD 🥳🥳🥳🥳. #diabetes #CardioSky #NephSky
www.frontiersin.org/journals/end...

Pleased to see this review article getting published where we incorporate clinical guidelines with latest evidence and experience in the management of T2DM in patients with ASCVD. Very grateful to all the coauthors for the help and input.
Frontiers | Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes - a review of evidence and recommendations
www.frontiersin.org
January 25, 2025 at 7:03 PM
Gorgeous winter walks to blow out the cobwebs 🥰🥰 #womeninstem #womeninscience #academicchatter #phdlife #phdchat #happysaturday #nephsky #cardiosky
January 25, 2025 at 1:10 PM